TY  - ADVS
AU  - Edelman,Martin
TI  - Development of a cancer drug
T2  - Cancer therapy : latest thinking in efficacy and toxicity,
PY  - 2022///
CY  - London
PB  - Henry Stewart Talks
KW  - United States
KW  - Food and Drug Administration
KW  - Antineoplastic agents
KW  - Development
KW  - Cancer
KW  - Chemotherapy
KW  - Clinical trials
KW  - Methodology
KW  - Drug approval
KW  - Law and legislation
KW  - Drug development
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Clinical Trials as Topic
KW  - legislation & jurisprudence
KW  - methods
KW  - Drug Approval
KW  - Neoplasms
KW  - drug therapy
KW  - Pharmaceutical Preparations
KW  - United States Food and Drug Administration
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Requirements for drug approval in the U.S. -- Legal evolution of drug approval -- The FDA and oncology drugs -- Clinical trial phases -- The effectiveness requirement -- Traditional and new approaches to trial design -- Types of controls -- Targeted therapies -- Companion diagnostics -- Endpoints for oncology trials -- Types of drug approval -- New drug application (NDA) -- Biomarkers -- FDA reviews and approvals; Access restricted to subscribers
UR  - https://hstalks.com/bs/4964/
UR  - https://hstalks.com/bs/p/385/
ER  -